Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07076641 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Intravenous Lidocaine Versus Placebo in Patients Receiving Morphine-rachi Analgesia

Study acronym: LIDORACHI
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Jul 2026 to Sep 2026v5
  2. Start date: Apr 2026 to Jul 2026v4
  3. Start date: Jan 2026 to Apr 2026v3
  4. Start date: Aug 1, 2025 to Jan 2026v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to evaluate the superiority of IV lidocaine combined with morphine spinal anesthesia versus placebo combined with morphine spinal anesthesia, in reducing postoperative morphine consumption at 48 hours, in patients undergoing major digestive or abdominal surgery by laparotomy.
Trial Details
NCT Number NCT07076641
Lead Sponsor GCS Ramsay Santé pour l'Enseignement et la Recherche
Collaborators: Euraxi Pharma
Conditions
(from sponsor)		 Digestive System Disease, Surgery
Related terms Digestive System Diseases
Enrollment 76 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov